Newsletter | 01 May 2006 Access News 13, Focus on R&D for 2006 World Health Assembly, May 2006 RESEARCH AND DEVELOPMENT This issue of AccessNews highlights the flaws in the R&D system – and the deadly consequences of those flaws. It also looks at possible solutions being discussed at the 2006 World Health Assembly. Read, watch, share Filter by - Any -EventsFact sheetFeature storyIssue briefLetterNewsletterPress releaseSpeechStatementTechnical briefVideo Statement | 28 June 2016 Hepatitis C WHO 69th World Health Assembly: Agenda item 15.1 - HIV and viral hepatitis, 2016 - 2021 Statement | 27 May 2016 Vaccines MSF intervention on Global Vaccine Action Plan at 66th WHA 3 min Statement | 23 May 2016 Intellectual property and trade WHO 69th World Health Assembly: Agenda item 16.4 Statement | 23 May 2016 Intellectual property and trade WHO 69th World Health Assembly: Agenda item 16.2 2 min Statement | 23 May 2016 Vaccines WHO 69th World Health Assembly: Agenda item 15.2 – Global Vaccine Action Plan Statement | 23 May 2016 WHO 69th World Health Assembly: Provisional agenda item 15.1 - HIV and viral hepatitis, 2016 - 2021 Statement | 23 May 2016 Antimicrobial resistance WHO 69th World Health Assembly: Agenda item 14.4 - Global Action Plan on Antimicrobial Resistance Events | 19 May 2016 Intellectual property and trade MSF at the 69th World Health Assembly Load More
Statement | 28 June 2016 Hepatitis C WHO 69th World Health Assembly: Agenda item 15.1 - HIV and viral hepatitis, 2016 - 2021
Statement | 23 May 2016 Intellectual property and trade WHO 69th World Health Assembly: Agenda item 16.4
Statement | 23 May 2016 Intellectual property and trade WHO 69th World Health Assembly: Agenda item 16.2 2 min
Statement | 23 May 2016 Vaccines WHO 69th World Health Assembly: Agenda item 15.2 – Global Vaccine Action Plan
Statement | 23 May 2016 WHO 69th World Health Assembly: Provisional agenda item 15.1 - HIV and viral hepatitis, 2016 - 2021
Statement | 23 May 2016 Antimicrobial resistance WHO 69th World Health Assembly: Agenda item 14.4 - Global Action Plan on Antimicrobial Resistance